Entrada Therapeutics Stock Price on January 31, 2025

TRDA Stock  USD 11.98  0.04  0.33%   
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 11.98, as last reported on the 28th of February, with the highest price reaching 12.51 and the lowest price hitting 11.81 during the day. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24 % return per unit of risk over the last 3 months. Entrada Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entrada Therapeutics' Standard Deviation of 3.43, variance of 11.74, and Mean Deviation of 2.56 to check the risk estimate we provide.
  
At present, Entrada Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 18.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 36.1 M. . At present, Entrada Therapeutics' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 10.32, whereas Price Earnings To Growth Ratio is projected to grow to (0.01). Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2372

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTRDA

Estimated Market Risk

 3.5
  actual daily
31
69% of assets are more volatile

Expected Return

 -0.83
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.24
  actual daily
0
Most of other assets perform better
Based on monthly moving average Entrada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding Entrada Therapeutics to a well-diversified portfolio.
Price Book
1.0647
Enterprise Value Ebitda
1.0075
Price Sales
2.0828
Shares Float
18.7 M
Wall Street Target Price
26.9275

Related Headline

Monte Rosa Headline on 31st of January 2025

Monte Rosa Therapeutics Is In A Good Position To Deliver On Growth Plans Yahoo Finance

Entrada Therapeutics Valuation on January 31, 2025

It is possible to determine the worth of Entrada Therapeutics on a given historical date. On January 31, 2025 Entrada was worth 13.53 at the beginning of the trading date compared to the closed value of 13.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entrada Therapeutics stock. Still, in general, we apply an absolute valuation method to find Entrada Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entrada Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entrada Therapeutics' related companies.
 Open High Low Close Volume
  13.49    13.65    13.24    13.37    100,018  
01/31/2025
  13.53    13.84    13.33    13.44    116,631  
  12.85    13.63    12.53    13.33    106,335  
Backtest Entrada Therapeutics  |  Entrada Therapeutics History  |  Entrada Therapeutics Valuation PreviousNext  
Open Value
13.53
13.44
Closing Value
24.03
Upside

Entrada Therapeutics Trading Date Momentum on January 31, 2025

On February 03 2025 Entrada Therapeutics was traded for  13.33  at the closing time. The top price for the day was 13.63  and the lowest listed price was  12.53 . The trading volume for the day was 106.3 K. The trading history from February 3, 2025 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.82% . The overall trading delta against the current closing price is 3.50% .
JavaScript chart by amCharts 3.21.1501/31/2025Jan 21Jan 24Jan 27Jan 30FebFeb 05Feb 0812.513.013.514.0

Entrada Therapeutics Fundamentals Correlations and Trends

By evaluating Entrada Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entrada financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Entrada Therapeutics Stock history

Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding39 M36.1 M
Net Loss-85.2 M-80.9 M

Entrada Therapeutics Quarterly Net Working Capital

394.73 Million

100%

Entrada Therapeutics Stock Technical Analysis

Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Entrada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entrada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Entrada Therapeutics Period Price Range

Low
February 28, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Entrada Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Entrada Therapeutics February 28, 2025 Market Strength

Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns

Entrada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Entrada Stock analysis

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Discover investing ideas

Utilize additional investing modules